Gwangju Alzheimer's & Related Dementia Cohort
Building the evidence to
overcome dementia — with data
GARD builds a large-scale multi-omics cohort — integrating clinical, genomic, brain-imaging and biospecimen data — to study the early diagnosis and prevention of dementia.
251TB+
Multi-omics data
Clinical · genomic · imaging · biospecimen
Multi-year
Longitudinal cohort
Longitudinal data accrual
SCI
Int’l publications
incl. Nature Communications
Research Pillars
Three research pillars
Cohort building & operation
We follow a large community-based cohort over time to observe changes before and after dementia onset.
Integrated multi-omics analysis
We integrate genomic, imaging, fluid-biomarker and clinical data to uncover the causes and progression of dementia.
Early diagnosis & prevention
We identify risk at the pre-symptomatic stage and build the evidence base for prevention and intervention.
News
Latest news
- 2026 GARD cohort findings published in an international journal Research
- 2026 Multi-omics data platform status released Notice
- 2025 AI-based brain imaging analysis results announced Research
Research collaboration & inquiries
We welcome inquiries on joint research, data use, and visits.
Contact us